VS
Therapeutic Areas
Gland Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Enoxaparin Sodium Injection | Anticoagulation / Deep Vein Thrombosis | Approved |
| Cefazolin Injection | Antibiotic / Surgical Prophylaxis | Approved |
| Heparin Sodium Injection | Anticoagulation | Approved |
| Biosimilar Pipeline (Confidential) | Oncology, Autoimmune Diseases | Development |
| CDMO Pipeline (Confidential Molecules) | Various (Oncology, Critical Care) | Phase 1 to Commercial |
| Complex Generics (Peptides/Hormones) | Diabetes, Endocrinology | Pre-clinical to Filing |
Leadership Team at Gland Pharma
SS
Srinivas Sadu
Managing Director & Chief Executive Officer
GS
G. S. Murthy
Chief Financial Officer
DR
Dr. Ravi Kumar
Chief Operating Officer
SK
S. K. Narayan
President - Global Business Development
DG
Dr. G. V. Prasad
Non-Executive Director (Chairman)
AF
Ami F. Patel
Non-Executive Director
JD
Jin Deyong
Non-Executive Director
GQ
Gong Qing
Non-Executive Director
DV
Dr. V. S. R. Krishnan
Independent Director
D(
Dr. (Mrs.) V. Mohan
Independent Director